The musculo-skeletal system medicine sales in Canada are forecasted to increase from CAD 1.21 billion in 2024 to CAD 1.28 billion in 2028. Comparing to the 2023 value of CAD 1.19 billion, the sector displays a stable growth trajectory. Year-on-year growth rates are modest, ranging from approximately 1.64% to 1.24%, indicating a consistent upward trend. The five-year compound annual growth rate (CAGR) is approximately 1.48%, reflecting steady market expansion.
Future trends to watch for include advances in biotechnology, rising prevalence of musculoskeletal disorders due to an aging population, and potential regulatory changes that could impact market dynamics. Innovations in personalized medicine and increased application of telehealth could further influence growth.
